HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenbo Guo Selected Research

Cavernous Transformation Of Portal Vein

4/2022Efficacy and safety of transcatheter arterial chemoembolization plus hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenbo Guo Research Topics

Disease

9Hepatocellular Carcinoma (Hepatoma)
10/2022 - 05/2018
8Neoplasms (Cancer)
04/2022 - 08/2018
2Neoplasm Metastasis (Metastasis)
12/2021 - 08/2019
1Neutropenia
11/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022
1Nausea
08/2022
1Hypertension (High Blood Pressure)
08/2022
1Exanthema (Rash)
08/2022
1Cavernous Transformation Of Portal Vein
04/2022
1Thrombosis (Thrombus)
04/2022
1Hypoxia (Hypoxemia)
01/2022
1Residual Neoplasm
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Liver Neoplasms (Liver Cancer)
07/2021
1Adenomyosis
03/2021
1Endometriosis
03/2021
1Body Weight (Weight, Body)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Pain (Aches)
01/2021
1Carcinogenesis
02/2019
1Lung Neoplasms (Lung Cancer)
02/2019
1Bacterial Infections (Bacterial Infection)
01/2019
1Dihydropyrimidine Dehydrogenase Deficiency
05/2018
1Fibrosis (Cirrhosis)
11/2016
1Hemorrhage
01/2013
1Rupture
01/2013
1Wounds and Injuries (Trauma)
01/2013
1Aneurysm (Aneurysms)
01/2013
1Hematoma
01/2013

Drug/Important Bio-Agent (IBA)

2RNA (Ribonucleic Acid)IBA
10/2022 - 01/2021
2pembrolizumabIBA
08/2022 - 10/2021
2lenvatinibIBA
08/2022 - 10/2021
2Capsules (Microcapsules)IBA
12/2021 - 01/2013
2Immune Checkpoint InhibitorsIBA
10/2021 - 09/2021
2Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2021
1Carboplatin (JM8)FDA LinkGeneric
11/2022
13-hydroxy-5-estrane-17-carbonitrile (ACN)IBA
11/2022
1130-nm albumin-bound paclitaxelIBA
11/2022
1B7-H1 AntigenIBA
11/2022
1atezolizumabIBA
11/2022
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2022
1Cytochromes c (Cytochrome c)IBA
01/2022
1Caspase 3 (Caspase-3)IBA
01/2022
1Caspase 8 (Caspase-8)IBA
01/2022
1LigandsIBA
12/2021
1aristolochic acid I (aristolochic acid)IBA
07/2021
1Small Cytoplasmic RNAIBA
01/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Aflatoxin M1 (Aflatoxin M)IBA
01/2021
1Aflatoxin B1 (Aflatoxin B)IBA
01/2021
1Cell-Free Nucleic AcidsIBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021
1GemcitabineFDA Link
01/2021
1Aspartic Acid (Aspartate)FDA Link
01/2021
1AntigensIBA
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1EsterasesIBA
01/2021
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2021
1anlotinibIBA
01/2020
1shuanglongIBA
02/2019
1Coal (Coals)IBA
02/2019
1Anti-Infective Agents (Microbicides)IBA
01/2019
1FlavonoidsIBA
08/2018
1Pharmaceutical PreparationsIBA
08/2018
1Biological ProductsIBA
08/2018
1tetramethylpyrazineIBA
08/2018
1UracilIBA
05/2018
1Fluorouracil (Carac)FDA LinkGeneric
05/2018
1dihydrouracilIBA
05/2018
1CreatinineIBA
01/2013

Therapy/Procedure

8Therapeutics
08/2022 - 01/2013
6Drug Therapy (Chemotherapy)
11/2022 - 06/2020
1Uterine Artery Embolization
03/2021
1Folfox protocol
06/2020